San Francisco, April 20, 2016 -- The Vitamin D Testing market is estimated to reach at more than CAGR of 32.35% from 2013 to 2018. The major reason for the development of this market is the increase in the geriatric population and chronic illness globally. The vitamin D testing market is observing approval for the increase in the products. Nevertheless, requirement for strict rules can present confront to the raise of the market.
Browse Full Research Report With TOC on http://www.radiantinsights.com/research/global-vitamin-d-testing-market-2014-2018
The market is estimated to observe a stable growth in the future. The viewpoint for the development of the market depends on features including major incidence of vitamin D shortage in the people resulting into moderate but slow growth of the market. The avoidance of different chronic and acute sickness is the major driver for the vitamin D testing market growth.
Chronic sicknesses like osteoporosis and rickets can occur due to deficiency of vitamin D. Vitamin D deficiency can also lead to asthma in infants, cardiovascular diseases, cognitive disorder, autoimmune diseases, and cancer. Frequent checking of the level of vitamin D in the body can reduce the occurrence of these diseases. This would in turn lower the overall expenditure related to healthcare.
See More Reports of This Category by Radiant Insights: www.radiantinsights.com/catalog/healthcare
The 25-Hydroxy vitamin D tests & 1, 25-Dihydroxy vitamin test sectors are estimated to be the largest market sector over the forecast period. At present this market sector holds a share of over three forth of the total market and is estimated to remain dominant over the forecast period. The capability of 25-Hydroxy vitamin D test has significant role in identifying bone weakness, bone softness & malfunction, or fracture in adult which is estimated to result in high share of the market over the forecast phase.
The market is extremely cutthroat and has companies focusing on research and development of tests. These companies compete on the ground of quality, product line width, price, technology, & distribution ability to get maximum importance in the market.
Get Sample Report Copy @ www.radiantinsights.com/research/global-vitamin-d-testing-market-2014-2018#tabs-4
The major companies in this market include Roche Diagnostics, Siemens Healthcare Diagnostics, Abbott Diagnostics, Quest Diagnostics, and Biomeriux Diasorin. Vitamin D testing kit at homes is gaining fame being highly price efficient.
Explore Other Reports By Radiant Insights,Inc at
- Butyl Acetate Markets –
http://www.radiantinsights.com/research/butyl-acetate-markets-in-china
- Cyanuramide Markets –
http://www.radiantinsights.com/research/cyanuramide-markets-in-china
About Radiant Insights
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy.Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Web: http://www.radiantinsights.com/


TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Washington Post Publisher Will Lewis Steps Down After Layoffs
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



